Otsuka Holdings
4578.T
#620
Rank
โ‚น2.831 T
Marketcap
โ‚น5,239
Share price
-0.15%
Change (1 day)
75.28%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Revenue for Otsuka Holdings (4578.T)

Revenue in 2024 (TTM): โ‚น1.205 Trillion

According to Otsuka Holdings 's latest financial reports the company's current revenue (TTM ) is โ‚น1.221 Trillion. In 2023 the company made a revenue of โ‚น1.181 Trillion an increase over the revenue in the year 2022 that were of โ‚น1.078 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Otsuka Holdings from 2010 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น1.205 T2.03%
2023 โ‚น1.181 T9.61%
2022 โ‚น1.078 T8.27%
2021 โ‚น995.73 B1.47%
2020 โ‚น981.29 B7.4%
2019 โ‚น913.67 B11.59%
2018 โ‚น818.79 B16.13%
2017 โ‚น705.07 B-5.51%
2016 โ‚น746.14 B-6.21%
2015 โ‚น795.51 B
2013 โ‚น874.46 B11.63%
2012 โ‚น783.36 B3.42%
2011 โ‚น757.44 B32.51%
2010 โ‚น571.59 B